CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | Lane Michael Executive Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −1,091 | 0 | ||
| 2021-08-03 | Lane Michael Executive Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −4,436 | 1,512 | ||
| 2021-07-30 | JUNIUS DANIEL M Director | Grant or award | +10 | $678.53 | $7K | 2,896 |
| 2021-07-30 | ESSIG STUART Director | Grant or award | +35 | $678.53 | $24K | 1,064 |
| 2021-07-30 | COLLINS Asha Director | Grant or award | +29 | $678.53 | $20K | 107 |
| 2021-05-28 | Turner Kathy V Senior Vice President | Sale | −2,000 | $558.44 | $1.1M | 2,866 |
| 2021-05-28 | Turner Kathy V Senior Vice President | Sale | −2,000 | $558.44 | $1.1M | 2,886 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +10,000 | $67.85 | $679K | 29,915 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,039 | $558.89 | $581K | 28,876 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,370 | $559.77 | $767K | 27,506 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,274 | $560.79 | $714K | 26,232 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,429 | $561.77 | $803K | 24,803 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −2,462 | $562.65 | $1.4M | 22,341 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,713 | $564.04 | $966K | 20,628 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −513 | $564.73 | $290K | 20,115 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Sale | −200 | $565.56 | $113K | 19,915 |
| 2021-05-28 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −10,000 | 2,627 | ||
| 2021-05-28 | AYERS JONATHAN W Director | Exercise or conversion | +9,460 | $79.54 | $752K | 654,161 |
| 2021-05-28 | AYERS JONATHAN W Director | Sale | −2,482 | $560.38 | $1.4M | 651,679 |
| 2021-05-28 | AYERS JONATHAN W Director | Sale | −1,664 | $561.57 | $934K | 650,015 |
Page 69 of 74 · 1,474 trades